DNA copy number alterations mark disease progression in paediatric chronic myeloid leukaemia
- PMID: 24673583
- DOI: 10.1111/bjh.12850
DNA copy number alterations mark disease progression in paediatric chronic myeloid leukaemia
Erratum in
- Br J Haematol. 2014 Nov;167(4):584
Abstract
Early recognition of children with chronic phase chronic myeloid leukaemia (CML-CP) at risk for developing a lymphoid blast crisis (LyBC) is desirable, because therapy options in CML-LyBC are limited. We used Multiplex Ligation-dependent Probe Amplification to determine whether B-cell lymphoid leukaemia-specific copy number alterations (CNAs) (e.g. IKZF1, PAX5, CDKN2A deletions) could be detected in CML-CP and may be used to predict disease progression to LyBC. CNAs were detected in all patients with CML-LyBC, but in none of the 77 patients with CML-CP. Based on this study we conclude that CNAs remain a hallmark of disease progression.
Keywords: IKZF1; copy number alterations; lymphoid blast crisis; paediatric CML.
© 2014 John Wiley & Sons Ltd.
Publication types
MeSH terms
Substances
Associated data
- Actions
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous